Bristol-Myers Squibb Co (NYSE:BMY)
| 65.64 Delayed Data As of Jun 02 |  +0.96 / +1.48%Today’s Change | 63.07 Today|||52-Week Range 81.44 | -8.77% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 64.68 |
| Today’s open | 65.00 |
| Day’s range | 64.55 - 65.78 |
| Volume | 6,768,783 |
| Average volume (3 months) | 8,044,670 |
| Market cap | $137.9B |
Data as of 4:00pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -5.67% |
| Earnings growth (this year) | +4.30% |
| Earnings growth (next 5 years) | +2.20% |
| Revenue growth (last year) | -0.49% |
| P/E ratio | 19.1 |
| Price/Sales | 3.35 |
| Price/Book | 4.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.55 | +1.09% |
| VRTXVertex Pharmaceutica... | +10.20 | +3.15% |
| REGNRegeneron Pharmaceut... | +8.82 | +1.21% |
| ZTSZoetis Inc | +5.87 | +3.54% |
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | July 27, 2023 |
| EPS forecast (this quarter) | $2.01 |
| Annual revenue (last year) | $46.2B |
| Annual profit (last year) | $6.3B |
| Net profit margin | 13.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
